Cutaneous leishmaniasis in a patient with psoriatic arthritis treated with tumour necrosis factor-α inhibitor

Scand J Rheumatol. 2024 Mar;53(2):158-159. doi: 10.1080/03009742.2023.2295627. Epub 2024 Jan 26.

Authors

N V Morsing¹, C M Andreasen¹, T A Rasmussen², L T Moll¹

Affiliations

¹ Department of Internal Medicine, Regional Hospital Gødstrup, Herning, Denmark.
² Department of Infectious Diseases, Aarhus University Hospital, Aarhus, Denmark.

PMID: 38275137
DOI: 10.1080/03009742.2023.2295627

No abstract available

MeSH terms

Antirheumatic Agents* / adverse effects
Arthritis, Psoriatic* / drug therapy
Humans
Immunologic Factors / therapeutic use
Leishmaniasis, Cutaneous* / diagnosis
Leishmaniasis, Cutaneous* / drug therapy
Tumor Necrosis Factor-alpha

Substances

Tumor Necrosis Factor-alpha
Antirheumatic Agents
Immunologic Factors